Jack W Callicutt
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $944K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jan 6SEC | GALTGalectin Therapeutics Inc | Sell Plan | 13,91453,700 held (−21%) | $4.20 | $58K | -6.2% |
| Jan 6SEC | GALTGalectin Therapeutics Inc | Sell Plan | 25,73227,968 held (−48%) | $3.90 | $100K | +1.0% |
| Jan 6SEC | GALTGalectin Therapeutics Inc | Sell Plan | 20,3547,614 held (−73%) | $3.67 | $75K | +7.4% |
| Nov 19SEC | GALTGalectin Therapeutics Inc | Sell Plan | 9,5867,614 held (−56%) | $6.03 | $58K | -34.7% |
| Nov 19SEC | GALTGalectin Therapeutics Inc | Sell Plan | 19,7017,614 held (−72%) | $6.03 | $119K | -34.7% |
| Nov 19SEC | GALTGalectin Therapeutics Inc | Sell Plan | 2,3237,614 held (−23%) | $6.03 | $14K | -34.7% |
| Nov 19SEC | GALTGalectin Therapeutics Inc | Sell Plan | 28,1007,614 held (−79%) | $6.22 | $175K | -36.7% |
| Nov 19SEC | GALTGalectin Therapeutics Inc | Sell Plan | 18,2107,614 held (−71%) | $6.22 | $113K | -36.7% |
| Nov 12SEC | GALTGalectin Therapeutics Inc | Sell Plan | 1,8807,614 held (−20%) | $6.02 | $11K | -34.6% |
| Nov 12SEC | GALTGalectin Therapeutics Inc | Sell Plan | 1,6757,614 held (−18%) | $6.03 | $10K | -34.7% |
| Nov 12SEC | GALTGalectin Therapeutics Inc | Sell Plan | 1,7367,614 held (−19%) | $6.03 | $10K | -34.7% |
| Nov 7SEC | GALTGalectin Therapeutics Inc | Sell Plan | 2007,614 held (−3%) | $6.00 | $1K | -34.3% |
| Nov 7SEC | GALTGalectin Therapeutics Inc | Sell Plan | 2007,614 held (−3%) | $6.00 | $1K | -34.3% |
| Nov 7SEC | GALTGalectin Therapeutics Inc | Sell Plan | 2007,614 held (−3%) | $6.00 | $1K | -34.3% |
| Nov 5SEC | GALTGalectin Therapeutics Inc | Sell Plan | 1,3007,614 held (−15%) | $6.01 | $8K | -34.4% |
| Nov 5SEC | GALTGalectin Therapeutics Inc | Sell Plan | 1,2607,614 held (−14%) | $6.01 | $8K | -34.4% |
| Nov 5SEC | GALTGalectin Therapeutics Inc | Sell Plan | 1,2507,614 held (−14%) | $6.01 | $8K | -34.4% |
| Nov 5SEC | GALTGalectin Therapeutics Inc | Sell Plan | 8,9147,614 held (−54%) | $6.07 | $54K | -35.1% |
| Nov 5SEC | GALTGalectin Therapeutics Inc | Sell Plan | 8,9747,614 held (−54%) | $6.07 | $54K | -35.1% |
| Nov 5SEC | GALTGalectin Therapeutics Inc | Sell Plan | 10,7417,614 held (−59%) | $6.07 | $65K | -35.1% |
- Sell
CFO Jack W Callicutt sold $58K of GALT at $4.20 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Jack W Callicutt sold $100K of GALT at $3.90 — cuts the stake by 48%; pre-scheduled 10b5-1 plan sale.
- Sell
CFO Jack W Callicutt sold $75K of GALT at $3.67 — cuts the stake by 73%; pre-scheduled 10b5-1 plan sale.
- Sell
CFO Jack W Callicutt sold $58K of GALT at $6.03 — cuts the stake by 56%; pre-scheduled 10b5-1 plan sale.
- Sell
CFO Jack W Callicutt sold $119K of GALT at $6.03 — cuts the stake by 72%; pre-scheduled 10b5-1 plan sale.
- Sell
CFO Jack W Callicutt sold $14K of GALT at $6.03 — pre-scheduled 10b5-1 plan sale.